CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 5, September/October 2017
284
AFRICA
doi: 10.1093/eurjhf/hfs105. PMID: 22828712.
17. Bangalore S, Kumar S, Messerli FH. When conventional heart failure
therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or
aldosterone antagonist?
Congest Heart Fail
2013;
19
: 107–115. doi: 10.1111/
chf.12011. PMID: 23241032.
18. Lang RM, Badano LP, Mor-Avi V,
et al
.
Recommendations for cardiac
chamber quantification by echocardiography in adults: an update from
the American Society of Echocardiography and the European Association
of Cardiovascular Imaging.
J Am Soc Echocardiogr
2015;
28
: 1–39.e14.
doi:10.1016/j.echo.2014.10.003. PMID: 25559473.
19. Nagueh SF, Appleton CP, Gillebert TC,
et al.
Recommendations for the
evaluation of left ventricular diastolic function by echocardiography.
Eur
J Echocardiogr
2009;
10
: 165–193. doi: 10.1093/ejechocard/jep007. PMID:
19270053.
20. Rudski LG, Lai WW, Afilalo J,
et al
. Guidelines for the echocardiographic
assessment of the right heart in adults: A report from the American
Society of Echocardiography endorsed by the European Association
of Echocardiography, a registered branch of the European Society of
Cardiology, and the Canadian Society of Echocardiography.
J Am Soc
Echocardiogr
2010;
23
: 685–713. doi: 10.1016/j.echo.2010.05.010. PMID:
20620859.
21. Reményi B, Wilson N, Steer A,
et al
. World Heart Federation criteria for
echocardiographic diagnosis of rheumatic heart disease – an evidence-based
guideline.
Nat Rev Cardiol
2012;
28
: 297–309. doi: 10.1038/nrcardio.2012.7.
PMID: 22371105.
22. Lancellotti P, Tribouilloy C, Hagendorff A,
et al
. Scientific document
committee of the European Association of Cardiovascular Imaging.
Recommendations for the echocardiographic assessment of native valvular
regurgitation: an executive summary from the European Association of
Cardiovascular Imaging.
Eur Heart J Cardiovasc Imaging
2013;
14
: 611–644.
doi: 10.1093/ehjci/jet105. PMID: 23733442.
23. Lancellotti P, Moura L, Pierard LA,
et al.
European Association of
Echocardiography recommendations for the assessment of valvular regurgi-
tation. Part 2: mitral and tricuspid regurgitation (native valve disease).
Eur J
Echocardiogr
2010;
11
: 307–332. doi: 10.1093/ejechocard/jeq031.
24. Cameli M, Caputo M, Mondillo S,
et al.
Feasibility and reference values
of left atrial longitudinal strain imaging by two-dimensional speckle track-
ing.
Cardiovasc Ultrasound
2009;
7
: 6. doi: 10.1186/1476-7120-7-6. PMID:
19200402.
25. Vianna-Pinton R, Moreno C, Baxter C,
et al.
Two-dimensional speckle-track-
ing echocardiography of the left atrium: feasibility and regional contraction
and relaxation differences in normal subjects.
J Am Soc Echocardiogr
2009;
22
: 299–305. doi: 10.1016/j.echo.2008.12.017. PMID: 19258177.
26. Younan H. Role of two dimensional strain and strain rate imaging in assess-
ment of left ventricular systolic function in patients with rheumatic mitral
stenosis and normal ejection fraction.
Egyptian Heart J
2015:
67
; 193–198.
doi:10.1016/j.ehj.2014.07.003.
27. Marciniak A, Claus P, Sutherland G,
et al
. Changes in systolic left ventricular
function in isolated mitral regurgitation. Strain rate imaging study.
Eur Heart
J
2007;
28
: 2627–2636. PMID: 17526904.
28. Kocabay G, Muraru D, Peluso D,
et al.
Normal left ventricular mechanics
by two-dimensional speckle-tracking echocardiography. Reference values
in healthy adults.
Rev Esp Cardiol
2014;
67
: 651–658.
doi.org/10.1016/j.rec.2013.12.009.
29. Kumar V, Jose V, Pati P,
et al
. Assessment of right ventricular strain and
strain rate in patients with severe mitral stenosis before and after balloon
mitral valvuloplasty.
Indian Heart J
2014;
16
: 176–182.
doi.org/10.1016/j.ihj.2014.02.012.
30. Todaro M, Romano G, Carerj S,
et al
. Right ventricular free wall strain:
a predictor of successful left ventricular assist device implantation.
Texas
Heart Inst J
2015
;
42
: 87–89.
doi.org/10.14503/THIJ-14-4111.31. Ellis LB, Ramirez A. The clinical course of patients with severe ‘rheumatic’
mitral insufficiency.
Am Heart J
1969;
78
: 406–418. PMID: 4241075.
32. Jhaveri S, Czoniczer G, Reider RB. Relatively benign ‘pure’ mitral regurgita-
tion of rheumatic origin. A study of seventy-four adult patients.
Circulation
1960;
22
: 39–48. PMID: 14407272.
33. Wilson MG, Lim WN. The natural history of rheumatic heart disease in the
third, fourth, and fifth decades of life. Prognosis with special reference to
survivorship.
Circulation
1957;
16
: 700–712. PMID: 13473042.
34. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D,
et al
. Quantitative
determinants of the outcome of asymptomatic mitral regurgitation.
N Engl
J Med
2005;
352
: 875–883. PMID: 15745978.
35. Rosenhek R, Rader F, Klaar U,
et al
. Outcome of watchful waiting in
asymptomatic severe mitral regurgitation.
Circulation
2006;
113
: 2238–2244.
PMID: 16651470.
36. Tribouilloy C, Grigioni F, Avierinos JF,
et al
. Survival implication of left
ventricular end-systolic diameter in mitral regurgitation due to flail leaf-
lets a long-term follow-up multicenter study.
J Am Coll Cardiol
2009;
54
:
1961–1968. doi: 10.1016/j.jacc.2009.06.047. PMID: 19909877.
37. Grigioni F, Enriquez-Sarano M, Ling LH,
et al.
Sudden death in mitral
regurgitation due to flail leaflet.
J Am Coll Cardiol
1999;
34
: 2078–2085.
PMID: 10588227.
38. Kligfield P, Hochreiter C, Niles N,
et al
. Relation of sudden death in pure
mitral regurgitation, with and without mitral valve prolapse, to repetitive
ventricular arrhythmias and right and left ventricular ejection fractions
. Am
J Cardiol
1987;
60
: 397–399. PMID: 3618505.
39. Grigioni F, Tribouilloy C, Avierinos JF,
et al
. Outcomes in mitral regurgita-
tion due to flail leaflets a multicenter European study.
J Am Coll Cardiol
Cardiovasc Imaging 2008
;
1
: 133–141. doi: 10.1016/j.jcmg.2007.12.005.
PMID: 19356418.
40. Muñoz S, Gallardo J, Diaz-Gorrin JR,
et al
. Influence of surgery on the
natural history of rheumatic mitral and aortic valve disease.
Am J Cardiol
1975;
35
: 234–242. PMID: 1119383.
41. Jeang MK, Petrovich LJ, Adyanthaya AV,
et al
. Effects of isosorbide dinitrate
on rheumatic and non-rheumatic mitral regurgitation.
Texas Heart Inst J
1986;
13
: 453–457. PMID: 15227354.
42. Therkelsen SK, Groenning BA, Svendsen JH,
et al
. Atrial and ventricular
volume and function evaluated by magnetic resonance imaging in patients
with persistent atrial fibrillation before and after cardioversion.
Am J Cardiol
2006;
97
: 1213–1219. PMID: 16616028.
43. Carabello B. Beta-blockade for mitral regurgitation. Could the management
of valvular heart disease actually be moving into the 21st century?
J Am Coll
Cardiol
2012;
60
: 839–840. PMID: 22818062.
44. Borer J. Mitral regurgitation: has another ‘magic bullet’ bitten the dust
? Circ
HeartFail
2013;
6
:624–626.doi:10.1161/CIRCHEARTFAILURE.113.000409.
PMID: 23861504.
45. Opie L, Gersh B. Inhibitors of the renin–angiotensin–aldosterone system. In:
Opie L, Gersh B (eds).
Drugs for the Heart
. 8th edn. Philadelphia: Elsevier
Saunders: 119–168.
46. Wei C, Chen Y, Powell L,
et al
. Cardiac kallikrein–kinin system is upregu-
lated in chronic volume overload and mediates an inflammatory induced
collagen loss.
PLoS One
2012;
7
. doi: 10.1371/journal.pone.0040110. PMID:
22768235.
47. Desai AS, Stevenson LW. Rehospitalization for heart fail-
ure: predict or prevent?
Circulation
2012;
126
: 501–506. doi: 10.1161/
CIRCULATIONAHA.112.125435. PMID: 22825412.
48. Tsutsui H, Spinale FG, Nagatsu M,
et al
. Effects of chronic beta-adrenergic
blockade on the left ventricular and cardiocyte abnormalities of chronic
canine mitral regurgitation.
J Clin Invest
1994;
93
: 2639–2648. PMID:
7911128.